Hereditary Angioedema Therapeutics Market Size, Share, Industry, Forecast and outlook (2024-2031)
Published: 2024 January 25
SKU : PH3504
180 pages
Report Summary
Table of Contents
List of Tables & Figures
Buy this report
Single User
$4350
Multiple User
$4850
Enterprise User
$7850
Request new version
FAQ’s
How big is the Hereditary Angioedema Therapeutics Market ?
Global Hereditary Angioedema Therapeutics Market reached USD 2.9 billion in 2022 and is projected to witness lucrative growth by reaching up to USD 5.4 billion by 2031.
Who are the key players in Hereditary Angioedema Therapeutics Market ?
Key plyers are BioCryst Pharmaceuticals, Inc, CSL Behring LLC, Takeda Pharmaceutical Company, Pharming Healthcare, Inc, Sanofi, Attune Pharmaceuticals, Inc, Ionis Pharmaceuticals, KalVista Pharmaceuticals, Inc, Arrowhead Pharmaceuticals, and Advanced Technology & Industrial Co., Ltd.
Related Reports
pharmaceuticalsFecal Incontinence Therapeutics Market Size, Share, Industry, Forecast and outlook (2023-2030)
Published: 2023 January 02
Starting from
$4350
pharmaceuticalsDiverticulitis Disease Treatment Market Size, Share, Industry, Forecast and outlook (2023-2030)
Published: 2023 January 02
Starting from
$4350
pharmaceuticalsGastroesophageal Reflux Disease Therapeutics Market Size, Share, Industry, Forecast and outlook (2023-2030)
Published: 2023 December 26
Starting from
$4350
pharmaceuticalsInhalation Anesthesia Market Size, Share, Industry, Forecast and outlook (2024-2031)
Published: 2024 April 23
Starting from
$4350
pharmaceuticalsKyphosis Treatment Market Size, Share, Industry, Forecast and outlook (2023-2030)
Published: 2022 October 03
Starting from
$4350
pharmaceuticalsUrinary Tract Cancer Treatment Market Size, Share, Industry, Forecast and outlook (2023-2030)
Published: 2023 October 06
Starting from
$4350